Member access

4-Traders Homepage  >  Shares  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  Cochlear Limited    COH   AU000000COH5

COCHLEAR LIMITED (COH)

8
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Cochlear Limited : COH Jury Trial Verdict on USA Patent Infringement Case

01/23/2014 | 09:51pm US/Eastern
Recommend:
0
ASX RELEASE 24th January 2014 COCHLEAR LIMITED: JURY TRIAL VERDICT ON USA PATENT INFRINGEMENT CASE

Cochlear Limited, Sydney, 24th January 2014 (ASX:COH) today announced that a jury verdict in the patent infringement lawsuit by the Alfred E. Mann Foundation for Scientific Research ("AMF") and Advanced Bionics LLC ("AB") has been reached.
A jury in the United States District Court in Los Angeles, California found direct, contributory and wilful, but not induced infringement against Cochlear Limited and its USA subsidiary Cochlear Americas and awarded damages of US$131.2 million against Cochlear.
No judgment has been entered based on the verdict as important issues still remain to be decided by the Judge. These decisions may negate some of the findings of the jury and could alter the damages awarded by the jury.
Cochlear believes the facts and the law do not support the jury's findings and will seek to overturn the verdict in post-trial motions with the District Court and, if necessary, through the appeals process.
This lawsuit was disclosed to ASX when it was filed in December 2007. The verdict relates to two (2) United States patents on testing systems and methods for a cochlear implant. The patents were exclusively licenced by AMF to AB which is a competitor to Cochlear.
One of the patents expired in September 2009 and the other expires in March 2014. As a result, the verdict and any following judgment entered against Cochlear will not disrupt Cochlear's business or customers in the United States.
As at the date of this announcement, Cochlear had not accrued any liability in its financial statements for this verdict. In addition, Cochlear has not yet determined the impact, if any, on its financial statements.
Cochlear's Chief Executive Officer and President Dr Chris Roberts said, "We strongly disagree with the jury verdict and will appeal any judgment entered against Cochlear by the Court".
Ends
Company contacts:
Dr Chris Roberts, CEO/President p: + 61 2 9428 6555
Neville Mitchell, CFO
p: + 61 2 9428 6555

Page 1 of 1

distributed by
Recommend :
0
React to this article
Latest news on COCHLEAR LIMITED
2d ago COCHLEAR : to unveil its Arabic Matrix Test at Annual Middle East Otolaryngology..
3d ago COCHLEAR : to unveil its Arabic Matrix Test at Annual Middle East Otolaryngology..
04/09 COCHLEAR : Patent Issued for Stimulus Timing for a Stimulating Medical Device
04/02 COCHLEAR : Patent Issued for Hearing Prosthesis with Integrated Sensors for Meas..
03/27 COCHLEAR : Patent Issued for Electrically Insulative Structure Having Holes for ..
03/26 COCHLEAR : Half Year Report 2014
03/26 COCHLEAR : Announces the FDA Approval and U.S. Launch of the First of Its Kind C..
03/06 COCHLEAR LIMITED : Patent Application Titled "Fitting Bilateral Hearing Prosthes..
03/05 COCHLEAR LIMITED : Patent Issued for Implantable Universal Docking Station for P..
02/28 COCHLEAR LIMITED : ex-dividend day for interim dividend
Advertisement
Chart
Duration : Period :
Cochlear Limited Technical Analysis Chart | COH | AU000000COH5 | 4-Traders
Income Statement Evolution
Cochlear Limited : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF